Introduction

▼
Depression is one of the most prevalent psychopathologies. Symptoms of depression include lowered mood, and reduced interest and pleasure. It is predicted by the World Health Organization to become the second leading cause of diseaserelated disability by the year 2020 [ 1 , 2 ] . Despite the introduction of tricyclic and monoamine oxidase inhibitors (MAOIs) and selective serotonin reuptake inhibitors (SSRIs) to treat depression, the therapeutic results have not been satisfactory. Only one-third of affl icted individuals have remission and the subjects always suff er from the side eff ects, such as anxiety, sleep disturbance, weight gain, and sexual dysfunction [ 3 -5 ] . Therefore, there is an unmet need for new antidepressants. Chalcones ( trans -1,3-diphenyl-2-propen-1-ones) are biogenetic precursors of fl avonoids [ 6 ] . Their chemical structure consists of open-chain fl avonoids in which 2 aromatic rings are joined by a 3-carbon α,β-unsaturated carbonyl system. They present a broad spectrum of biological activities, such as anti-tumor, anti-oxidation, anti-infl ammatory, antiviral, antilipidemic, and antidepressant activities [ 7 -12 ] . Previously, our research team found that isoliquiritigenin and butein ( • ▶ Fig. 1 ) showed antidepressant-like eff ects in the forced swimming test (FST; p < 0.05 and p < 0.01, respectively) in mice,
In this study, twelve 2,4-dihydroxychalcone derivatives were synthesized and evaluated for antidepressant activities using the forced swimming test (FST). The pharmacological test showed that 6 compounds signifi cantly reduced the immobility times in the FST at a dose of 10 mg/kg, indicative of antidepressant activity. Among the derivatives, compounds designated 3d and 3 h exhibited the best antidepressant activity, with reduced immobility time by 32 .05 % and 34.33 %, respectively. In the 5-hydroxytryptophan-induced head-twitch test and yohimbine-induced mortality test, compounds 3d and 3 h increased head-twitch and increased the mortality rate. The mechanisms of the antidepressant eff ects of compounds 3d and 3 h may be related with the 5-HTP and NE nervous system.
Synthesis of 2′-hydroxy-3-bromo-4′-methoxymethoxychalcone(2d)
To a stirred solution of 15 % KOH cooled to 0 °C in an ice bath was added dropwise a solution of 2-hydroxy-4-methoxymethoxyactetophenone (2.0 mmol) and 3-bromobenzaldehyde (4.0 m mol) in ethanol under nitrogen. The reaction mixture was kept at room for 8 h. The mixture was poured into the ice-water, adjusted to pH 2-3 with 1 M HCl, and the extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over anhydrous Na 2 SO 4 [ 18 ] . After removing solvents, the product was recrystallized from ethanol. General procedure for the preparation of compounds(3a-l)
In a round-bottomed fl ask, to a stirred solution of chalcones 2a-l (0.25 mmol) in methanol was added dropwise 3 M HCl, the mixture was refl uxed for 30 min. The solvents were removed under the reduced pressure and diluted with water, and extracted with ethyl acetate. The organic layer was washed with water and brine, dried over anhydrous Na 2 SO 4 . After concentration under reduced pressure, the resultant was recrystallized from ethanol [ 19 ] . The yield, melting point and spectral data of part compounds are given below. 
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Pharmacology Animals
Male Kunming mice weighing 20-24 g (Laboratory of Animal Research, College of Pharmacy, Yanbian University, Yanji, Jilin, China) were used in this study. Mice were housed collectively in groups of 10 in polycarbonate cages. They were maintained on a 12 h light/dark cycle in a temperature controlled (22-25 °C) laboratory. Food and water were available ad libitum. All procedures used in the present study were in accordance with the Guide for the Care and Use of Laboratory Animals as adapted by the NIH (Bethesda, MD, USA). All eff orts were made to minimize animal suff ering and to reduce the number of animals used.
Forced swimming test (FST)
The FST used was the same as described in detail elsewhere Porsolt [ 14 , 15 ] . The synthesized compounds were screened for their antidepressant activity. Local breed, male Kunming mice (20-24 g) were used in the forced swimming test under standard conditions with free access to food and water. They were housed in groups of 6, In the experiment, mice were assigned into diff erent groups (n = 10 for each group). The synthesized compounds (10 mg/kg) and fl uoxetine as a reference antidepressant drug (10 mg/kg) were dissolved in DMSO through injected intraperitoneally ( ip ) in a standard volume of 0.05 mL/20 g body weight, 30 min prior to the test. Briefl y, mice were individually placed in a glass cylinder (25 cm in height, 10 cm in diameter fi lled with 10-cm high of water 22-25 °C). Each mouse was given a 6-min swimming test, and the duration of immobility was observed and measured during the fi nal 4-min interval of the test. All test swim sessions were recorded by a video camera positioned directly above the cylinder. 2 competent observers, who were unaware of the treatment each mouse had received, scored the videotapes. Immobility period was regarded as the time spent by the mouse fl oating in the water without struggling and making only those movements necessary to keep its head above the water. Following swimming sessions, they were then towel dried and returned to their housing condition. The animals were used only once in this test. All FSTs were performed between 12:00 a.m. and 19:00 p.m.
Tail suspension test (TST)
The TST was conducted as previously described [ 21 ] . Briefl y, the synthesized compounds (10 mg/kg) and fl uoxetine as a reference antidepressant drug (10 mg/kg) were dissolved in DMSO through injected intraperitoneally ( ip ) in a standard volume of 0.05 mL/20 g body weight, 30 min prior to the test. Then, mice were individually suspended by tail with clamp (2 cm from the tip of the end) in a box (25 × 25 × 30 cm) with the head 5 cm to the bottom. Testing was carried out in a darkened room with minimal background noise. All animals were suspended for total 6 min, and the duration of immobility was observed and measured during the fi nal 4-min interval of the test. All test sessions were recorded by a video camera positioned directly above the box. 2 competent observers blind to treatment scored the videotapes. Mice consider immobile only when they hung passively and completely motionless. The animals were used only once in this test. All TSTs were performed between 12:00 a.m. and 16:00 p.m.
Hydroxytryptophan(5-HTP) induced mouse head-twitch test
To investigate whether the serotonergic system was involved in the antidepressant-like eff ect of compounds 3d and 3 h, we performed a 5-HTP induced head-twitch test [ 22 , 23 ] . Totally 24 male Kunming (20-25 g) mice were randomly chosen and divided into 3 groups normal control group, group of compounds 3d and 3 h, and positive control (fl uoxetine). Mice were administered a i.p. injection with compounds 3d and 3 h (30 mg/ kg), fl uoxetine (30 mg/kg) 60 min before 5-HTP (100 mg/kg, i.p.). Immediately after the second injection, mice were placed into plastic cages. 10 min later, the cumulative number of head twitches (rapid movements of the head with little or no involvement of the trunk) was recorded for 6 min. All test sessions were recorded by a video camera. The animals were used only once in this test, the head-twitch tests were performed between 10:00 a.m. and 12:00.
Yohimbine toxicity potentiation test
To trveal whether the noradrenergic system is involved in the antidepressant-like eff ect of the compounds 3d and 3 h, the yohimbine toxicity potentiation test was performed [ 22 ] .Totally 24 male Kunming (20-25 g) mice were randomly chosen and divided into 3 groups: normal control group, group of the compounds 3d and 3 h, and positive control group (clomipramine), clomipramine (30 mg/kg)(i.p.), 1 h prior to yohimbine administration (20 mg/kg, s.c.). The number of dead mice was calculated during a 20 h period after the injection of yohimbine.
Statistical analysis
Results are expressed as mean ± S.E.M.; n represents the number of animals. Data obtained from pharmacological experiments were analyzed with 1-way analysis of variance (ANOVA) followed by Dunnet's post hoc test, using Pharmacologic Calculation System Version 4. 
Results and Discussion
▼ Chemistry
The target compounds 3a-l were synthesized as outlined • ▶ Fig. 2 .
Compound 1 was prepared as reported previously in the literature [ 13 ] . The intermediates 2a-l were prepared by the Claisen-Schmidt condensation reaction from compound 1, with appropriate aromatic aldehydes, protected as chloromethyl methyl ether in EtOH at room temperature in high yields [ 19 , 24 ] . Then 2,4-dihydroxychalcone derivatives (3a-l) were obtained with 3 M HCl in methanol in good yield [ 25 ] ( • ▶ Fig. 2 ). The structures of these compounds were confi rmed by IR, 1 H-NMR, or 13 C-NMR, mass spectrometry, and elementary analysis.
Pharmacological evaluations
The forced swimming test (FST) and the tail suspension test (TST) were designed by Porsolt et al. and Steru L et al. as a primary screening test for antidepressants. FST and TST are behavioral tests used to predict the effi cacy of antidepressant treatments [ 14 , 15 ] . They are two of the best models for this purpose for several reasons. They are used eff ectively in predicting the activity of a wide variety of antidepressants, and are lowcost, fast and reliable models to test potential antidepressant treatments with strong predictive validity. The immobility time observed in the test refl ects a state of lowered mood or hopelessness in the animal. Thus, these animal models are the most widely used tools for preclinical screening of putative antidepressant agents, and have good predictive value for antidepressant potency in humans [ 26 , 27 ] . In the present study, 12 compounds were described for their antidepressant activities in mice using the FST. The pharmacological tests revealed that 6 compounds showed good antidepressant activities. Acute treatment with compounds 3b, 3d, 3 g, 3 h, 3i, and 3 l signifi cantly promoted a decrease in the immobility time in the FST at 10 mg/kg, as depicted in • ▶ Fig. 3 (control = 116.7 ± 12.3; 3b = 86.7 ± 14.5; 3d = 79.3 ± 9.2; 3g = 89.8 ± 7.8; 3h = 76.7 ± 7.9; 3i = 82.5 ± 18.7; 3l = 93.8 ± 17.7; fl uoxetine = 68.6 ± 8.3). The immobi lity time of mice treated with compounds 3a, 3c, 3e, 3f, 3j, and 3k did not statistically diff er from control values, as shown in • ▶ Fig. 4 (control = 116.7 ± 12.3; 3a = 96.3 ± 31.2; 3c = 95.2 ± 12.6; 3e = 111.7 ± 10.5; 3f = 105.8 ± 11.6; 3j = 97.5 ± 15.6; 3k = 98.5 ± 6.5; fl uoxetine = 68.6 ± 8.3). Among, 2 compounds, 3d (3-bromo-2′,4′-dihydrox-ychalcone) and 3h (2,6-dichloro-2′,4′-dihydroxychalcone) were found to be the most potent, and signifi cantly reduced the duration of immobility times at the 10 mg/kg dose level when compared with the control ( p < 0.001). Generally, the activity of an organic compound is markedly increased after the introduction of a halogen atom. Therefore, in this paper some halogen-substituted derivatives were designed and synthesized. Analyzing the antidepressant activity of the synthesized compounds 3a-l, the following SAR was derived. 
Duration of immobility (s)
Control FLU 3b 3d 3g 3h 3i 3l The immobility has been shown to refl ect a state of 'behavioral despair and variants' or 'failure to adapt to stress' [ 26 ] . The immobility displayed in both of these behavioural despair models has been hypothesized to refl ect depressive disorders in human. There was a signifi cant correlation between clinical potency and the potency of antidepressants in both models. Compounds 3d and 3h signifi cantly produced antidepressantlike activity in both the FST and TST in mice, which indicates that compounds 3d and 3 h possess some antidepressant eff ects. Finally, 2 behavioural models were used to investigate the possible monoaminergic participation in the antidepressant activity. Compounds 3d and 3h, as the most active compounds, were chosen for the behavioural tests. Compounds 3d and 3h signifi cantly increased the cumulative number of head twitches ( p < 0.05 vs. control) in the 5-HTP-induced mouse head-twitch test, whereas it enhanced the mouse lethality ( p < 0.05 vs. control) induced by yohimbine. The results indicate that the serotonergic, but not the noradrenergic system, was involved in the antidepressant-like eff ect of compounds 3d and 3h ( • ▶ Fig. 4 Eff ects of the acute treatments with the compounds(10 mg/kg) and fl uoxetine (FLU, 10 mg/ kg i.p.) on the immobility time in FST. Each column represents the mean ± S.E.M. * p < 0.05 as compared with control (all comparisons were made by ANOVA followed by Dunnett's test).
Fig. 5
Immobility time of the compounds 3d and 3 h in mouse TST after intraperitoneal administration in mice (i.p.) at 10 mg/kg. Data are expressed as mean ± S.E.M. ( n = 10). Statistical analysis of the data was carried out by one-way analysis of variance followed by the t-test. * p < 0.05, *** p < 0.001 vs. control. This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited.
eff ective method to evaluate serotonergic eff ects of drugs in vivo [ 30 ] . It has been generally accepted that the number of head twitches represent the level of 5-hydroxytryptamine (5-HT) in the synapses. Yohimbine is an a 2 -adrenergic released by its antagonistic action on the presynaptic a 2 -adrenoceptor [ 31 ] .
The yohimbine toxicity potentiation test is usually used for the evaluation of noradrenergic eff ect of antidepressants [ 32 ] .
Conclusions
▼
In conclusion, twelve 2,4-dihydroxychalcone compounds were synthesized and evaluated for their antidepressant activity using the FST and TST tests. 6 compounds showed antidepressant activity at a dose of 10 mg/kg i.p. Among the compounds, 3d and 3h had the most antidepressant activity, and signifi cantly reduced the duration of immobility times when compared with the control ( p < 0.001) in the FST. Further studies are needed to reveal the mechanism of the antidepressant-like eff ect of compounds 3d and 3 h. 
